Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$2.09 - $3.71 $31,216 - $55,412
-14,936 Reduced 81.46%
3,400 $11,000
Q1 2022

May 13, 2022

SELL
$2.84 - $4.52 $4,651 - $7,403
-1,638 Reduced 8.2%
18,336 $56,000
Q4 2021

Feb 11, 2022

SELL
$3.87 - $6.59 $226,518 - $385,725
-58,532 Reduced 74.56%
19,974 $89,000
Q3 2021

Nov 04, 2021

SELL
$6.22 - $15.54 $914 - $2,284
-147 Reduced 0.19%
78,506 $515,000
Q2 2021

Aug 11, 2021

BUY
$10.15 - $17.25 $82,306 - $139,880
8,109 Added 11.49%
78,653 $1.26 Million
Q1 2021

May 13, 2021

BUY
$10.6 - $21.27 $711,726 - $1.43 Million
67,144 Added 1974.82%
70,544 $872,000
Q3 2020

Nov 12, 2020

SELL
$1.82 - $5.87 $21,476 - $69,266
-11,800 Reduced 77.63%
3,400 $17,000
Q2 2020

Aug 13, 2020

SELL
$1.41 - $2.61 $1,519 - $2,813
-1,078 Reduced 6.62%
15,200 $29,000
Q1 2020

May 14, 2020

SELL
$1.28 - $4.5 $16,705 - $58,729
-13,051 Reduced 44.5%
16,278 $31,000
Q4 2019

Feb 14, 2020

BUY
$4.03 - $9.22 $103,317 - $236,373
25,637 Added 694.39%
29,329 $130,000
Q3 2019

Nov 14, 2019

SELL
$8.31 - $13.03 $54,272 - $85,098
-6,531 Reduced 63.89%
3,692 $30,000
Q2 2019

Aug 14, 2019

SELL
$9.0 - $17.2 $49,302 - $94,221
-5,478 Reduced 34.89%
10,223 $126,000
Q1 2019

May 15, 2019

BUY
$13.6 - $19.58 $122,685 - $176,631
9,021 Added 135.04%
15,701 $237,000
Q4 2018

Feb 14, 2019

SELL
$16.0 - $31.84 $126,720 - $252,172
-7,920 Reduced 54.25%
6,680 $128,000
Q3 2018

Dec 21, 2021

BUY
$24.32 - $37.54 $40,930 - $63,179
1,683 Added 13.03%
14,600 $468,000
Q3 2018

Nov 14, 2018

BUY
$24.32 - $37.54 $314,141 - $484,904
12,917 New
12,917 $413,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $125M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.